Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB4846
CAS No: 1071001-09-6
Chemical Name: 1,1,1-Trifluoro-6-(2-naphthalenyl)-2-hexanone
Warning: Last items in stock!
Availability date:
Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $9.90 | Total: $990.00 |
1 | 50 | $11.44 | Total: $572.00 |
1 | 25 | $13.42 | Total: $335.50 |
1 | 10 | $15.84 | Total: $158.40 |
1 | 5 | $18.70 | Total: $93.50 |
Molecular Formula | C16H15F3O |
Molecular Weight | 280.28 |
CAS Numbers | 1071001-09-6 |
Synonym | FKGK18; FKGK-18; FKGK 18 |
IUPAC/Chemical Name | 1,1,1-trifluoro-6-(2-naphthalenyl)-2-hexanone |
InChl Key | VCWWTQMRNJSJGC-UHFFFAOYSA-N |
InChl Code | InChI=1S/C16H15F3O/c17-16(18,19)15(20)8-4-1-5-12-9-10-13-6-2-3-7-14(13)11-12/h2-3,6-7,9-11H,1,4-5,8H2 |
SMILES Code | O=C(C(F)(F)F)CCCCC1=CC2=CC=CC=C2C=C1 |
References | 1) Kokotos, G., et al. Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2. J. Med. Chem. 53(9), 3602-3610 (2010). 2) Ali, T., et al. Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): Candidate drug for preventing β-cell apoptosis and diabetes. PLoS One 8(8):e71748, (2013). 3) Bone, R.N., et al. Inhibition of Ca2+-independent phospholipase A2β (iPLA2β) ameliorates islet infiltration and incidence of diabetes in NOD mice. Diabetes 64(2), 541-554 (2015). |
Novel Inhibitor of Group VIA Ca(2+)-Independent Phospholipase A2 (iPLA2β) for Preventing Beta-Cell Apoptosis and Diabetes